4.6 Article

Enhanced Immunogenicity of an Influenza Ectodomain Matrix-2 Protein Virus-like Particle (M2e VLP) Using Polymeric Microparticles for Vaccine Delivery

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Pharmacology & Pharmacy

A dual-delivery platform for vaccination using antigen-loaded nanoparticles in dissolving microneedles

Keegan Braz Gomes et al.

Summary: Effective vaccines delivered via painless methods would revolutionize vaccination. This study developed fast-dissolving microneedles to deliver antigen-loaded polymeric nanoparticles, achieving a dual-delivery platform for transdermal vaccination. The study demonstrated the feasibility of this approach and its potential for transdermal vaccine administration.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2022)

Article Pharmacology & Pharmacy

Dendritic cell activation by a micro particulate based system containing the influenza matrix-2 protein virus-like particle (M2e VLP)

Kimberly Braz Gomes et al.

Summary: This study examined the activation status of dendritic cells (DCs) and the innate and adaptive immune responses after exposure to M2e VLP vaccine. Results showed that the M2e VLP microparticle had a strong stimulatory effect on DCs, and the presence of Alhydrogel(R) and MPL-A(R) adjuvants enhanced this effect.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2022)

Article Immunology

Transdermal Immunization with Microparticulate RSV-F Virus-like Particles Elicits Robust Immunity

Sucheta D'Sa et al.

Summary: There are currently no approved vaccines for RSV infections, but a study found that the transdermal delivery of RSV-F VLP microparticulate vaccine has the potential to trigger robust immune responses, effectively clearing lung viruses and preventing weight loss.

VACCINES (2022)

Article Pharmacology & Pharmacy

Nanoparticle formulation of the fusion protein virus like particles of respiratory syncytial virus stimulates enhanced in vitro antigen presentation and autophagy

Ipshita Menon et al.

Summary: Respiratory Syncytial Virus (RSV) is a major cause of bronchiolitis and pneumonia in children under one year globally. This study demonstrates the potential of using polymeric nanoparticles as a delivery system for RSV vaccines, leading to enhanced antigen presentation and induction of autophagy.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2022)

Article Immunology

Transdermal Vaccination with the Matrix-2 Protein Virus-like Particle (M2e VLP) Induces Immunity in Mice against Influenza A Virus

Kimberly Braz Gomes et al.

Summary: The study utilized the highly conserved M2e VLP as a potential vaccine candidate against influenza, showing promising immunogenic potential and protective effects when administered transdermally in a pre-clinical mouse model.

VACCINES (2021)

Article Immunology

M2e conjugated gold nanoparticle influenza vaccine displays thermal stability at elevated temperatures and confers protection to ferrets

Rohan S. J. Ingrole et al.

Summary: Currently approved influenza vaccines have limited protection and shelf-life. Researchers have developed a thermally stable vaccine with broad protective abilities, showing efficacy at different storage temperatures in animal models.

VACCINE (2021)

Review Immunology

Universal influenza vaccines: from viruses to nanoparticles

Ye Wang et al.

EXPERT REVIEW OF VACCINES (2018)

Article Chemistry, Medicinal

A Perspective on Nanoparticle Universal Influenza Vaccines

Lei Deng et al.

ACS INFECTIOUS DISEASES (2018)

Article Pharmacology & Pharmacy

Physicochemical and Preclinical Evaluation of a Novel Buccal Measles Vaccine

Rikhav P. Gala et al.

AAPS PHARMSCITECH (2017)

Article Pharmacology & Pharmacy

A Design of Experiment approach to predict product and process parameters for a spray dried influenza vaccine

Gaurav Kanojia et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2016)

Review Immunology

Mechanisms of Cross-protection by Influenza Virus M2-based Vaccines

Yu-Na Lee et al.

IMMUNE NETWORK (2015)

Review Pharmacology & Pharmacy

Laser microporation of the skin: prospects for painless application of protective and therapeutic vaccines

Sandra Scheiblhofer et al.

EXPERT OPINION ON DRUG DELIVERY (2013)

Article Medicine, Research & Experimental

Intranasal Administration of the TLR2 Agonist Pam2Cys Provides Rapid Protection against Influenza in Mice

Amabel C. L. Tan et al.

MOLECULAR PHARMACEUTICS (2012)

Review Chemistry, Multidisciplinary

Designing polymeric particles for antigen delivery

Stefaan De Koker et al.

CHEMICAL SOCIETY REVIEWS (2011)

Review Biotechnology & Applied Microbiology

Multifunctional dendritic cell-targeting polymeric microparticles Engineering new vaccines for type 1 diabetes

Benjamin G. Keselowsky et al.

HUMAN VACCINES (2011)

Review Microbiology

Polymeric particles in vaccine delivery

Allison C. Rice-Ficht et al.

CURRENT OPINION IN MICROBIOLOGY (2010)

Review Chemistry, Multidisciplinary

Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles

Felix Kratz

JOURNAL OF CONTROLLED RELEASE (2008)

Review Immunology

Phagocytosis and antigen presentation in dendritic cells

Ariel Savina et al.

IMMUNOLOGICAL REVIEWS (2007)

Review Immunology

Influenza and the challenge for immunology

PC Doherty et al.

NATURE IMMUNOLOGY (2006)

Review Biochemical Research Methods

Microparticle-based technologies for vaccines

Derek T. O'Hagan et al.

METHODS (2006)

Review Biochemistry & Molecular Biology

Taking toll: lipid A mimetics as adjuvants and immunomodulators

DH Persing et al.

TRENDS IN MICROBIOLOGY (2002)